Drug Type Small molecule drug |
Synonyms Pancopride (USAN/INN), LAS 30451, LAS-30451 |
Target |
Action antagonists |
Mechanism 5-HT3 receptor antagonists(5-hydroxytryptamine receptors, ionotropic (HTR3) antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H24ClN3O2 |
InChIKeyDBQMQBCSKXTCIJ-UHFFFAOYSA-N |
CAS Registry121650-80-4 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D05348 | - | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nausea | Phase 3 | - | - | |
| Nausea and vomiting | Phase 3 | Spain | - |





